114 related articles for article (PubMed ID: 2503975)
21. Clinical, histopathological and bacteriological study of 52 referral MB cases relapsing after MDT.
Shetty VP; Wakade AV; Ghate SD; Pai VV; Ganapati RR; Antia NH
Lepr Rev; 2005 Sep; 76(3):241-52. PubMed ID: 16248211
[TBL] [Abstract][Full Text] [Related]
22. Auramine staining in histopathology sections.
Bhatia VN; Rao S; Saraswathi G
Indian J Lepr; 1987; 59(4):386-9. PubMed ID: 2454272
[TBL] [Abstract][Full Text] [Related]
23. Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.
Ebenezer GJ; Job A; Abraham S; Arunthathi S; Rao PS; Job CK
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):292-7. PubMed ID: 10575409
[TBL] [Abstract][Full Text] [Related]
24. Bacillaemia in leprosy: correlation with slit-skin and nasal smears.
Chatterjee G; Kaur S; Sharma VK; Vaishnavi C; Kaur I
Indian J Lepr; 1988 Oct; 60(4):535-41. PubMed ID: 3075633
[TBL] [Abstract][Full Text] [Related]
25. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy.
Kumar A; Girdhar A; Girdhar BK
Acta Leprol; 2003; 12(3):123-8. PubMed ID: 15040703
[TBL] [Abstract][Full Text] [Related]
26. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
Vijayakumaran P; Manimozhi N; Jesudasan K
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
[TBL] [Abstract][Full Text] [Related]
27. Lepromatous leprosy treated with combined chemotherapy and immunotherapy (injection BCG): three case reports.
Lakshmi C; Srinivas CR
Int J Dermatol; 2014 Jan; 53(1):61-5. PubMed ID: 23675902
[TBL] [Abstract][Full Text] [Related]
28. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine.
Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):259-69. PubMed ID: 10575405
[TBL] [Abstract][Full Text] [Related]
29. The histopathology of lepromatous leprosy in the nose.
McDougall AC; Rees RJ; Weddell AG; Kanan MW
J Pathol; 1975 Apr; 115(4):215-26. PubMed ID: 1099180
[TBL] [Abstract][Full Text] [Related]
30. Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study.
Costa MB; Cavalcanti Neto PF; Martelli CM; Stefani MM; Maceira JP; Gomes MK; Schettini AP; Rebello PF; Pignataro PE; Ueda ES; Narahashi K; Scollard DM
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):177-86. PubMed ID: 11875761
[TBL] [Abstract][Full Text] [Related]
31. A bacteriological assessment of multibacillary cases in leprosy colonies after 4 1/2 years of multidrug therapy.
Naik SS; Bhanage ND; Sawant KV; Ganapati R
Indian J Lepr; 1988 Jul; 60(3):393-9. PubMed ID: 3058827
[TBL] [Abstract][Full Text] [Related]
32. Study of apparently uninvolved skin in leprosy as regards bacillary population at various sites.
Kaur S; Kumar B
Lepr India; 1978 Jan; 50(1):38-44. PubMed ID: 349263
[TBL] [Abstract][Full Text] [Related]
33. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT).
Rada E; Ulrich M; Aranzazu N; Rodriguez V; Centeno M; Gonzalez I; Santaella C; Rodriguez M; Convit J
Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):320-7. PubMed ID: 9401484
[TBL] [Abstract][Full Text] [Related]
34. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
35. Use of reverse transcription polymerase chain reaction for the detection of Mycobacterium leprae in the slit-skin smears of leprosy patients.
Jadhav RS; Kamble RR; Shinde VS; Edward S; Edward VK
Indian J Lepr; 2005; 77(2):116-27. PubMed ID: 16044809
[TBL] [Abstract][Full Text] [Related]
36. Multibacillary leprosy presenting as a solitary skin lesion; report of three cases and its significance in control programs.
Ramesh V; Saxena U; Misra RS; Mukherjee A; Ravi S
Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):1-4. PubMed ID: 2030305
[TBL] [Abstract][Full Text] [Related]
37. Immunotherapeutic potential of ICRC vaccine: a case control study.
Bhatki WS; Chulawala RG
Lepr Rev; 1992 Dec; 63(4):358-64. PubMed ID: 1479876
[TBL] [Abstract][Full Text] [Related]
38. Clinico-pathological study of so-called immune zones in leprosy.
Sahni U; Reddy BS; Malik R
Lepr India; 1982 Apr; 54(2):256-62. PubMed ID: 6752577
[TBL] [Abstract][Full Text] [Related]
39. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy.
Job CK; Jayakumar J; Aschhoff M; Mathan MM
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112
[TBL] [Abstract][Full Text] [Related]
40. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]